 | | PRD_002519 | | Name: | MCR-PHE-VAL-PRO-THR-THR-BIF-MAA-BIF-MAA-GLU-ALA-PRO-ALA-NEH inhibitor | | Formula: | C85 H110 N14 O18 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002520 | | Name: | ACE-PHE-VAL-DAB-THR-THR-PHE-MAA-BIF-YBR inhibitor | | Formula: | C62 H80 N10 O14 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002521 | | Name: | YBX-YC3-VAL-PRO-THR-THR-PHE-MAA-CYS-MN1 inhibitor | | Formula: | C60 H81 N9 O13 S3 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002523 | | Name: | MCR-ALO-MAA-ALA-MAA-NLE-7T2-SER-7T2-ALA-NH2 inhibitor | | Formula: | C49 H70 Cl2 N10 O12 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002525 | | Name: | PPI-YD5-NLE-7T2-SER-7T2-DPP-GLY-NH2 inhibitor | | Formula: | C43 H59 Cl2 N9 O10 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002554 | | Name: | MCR-ALA-7T2-GLY-004-7T2-SER-7T2-0NC inhibitor | | Formula: | C52 H60 Cl3 N9 O10 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002558 | | Name: | DGN-DVA-YC3-GLU-PRO-THR-THR-PHE-MAA-A1BC0 inhibitor | | Formula: | C62 H84 N12 O14 S2 | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002562 | | Name: | MCR-ALA-7T2-GLY-004-7T2-SER-7T2-ALA-GLY-NH2 inhibitor | | Formula: | C53 H61 Cl3 N10 O11 S | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002583 | | Name: | Peptidoglycan disaccharide tetrapeptide | | Formula: | C37 H63 N9 O19 | | Description: | Peptidoglycan is composed of glycan strands and peptide stems. In this instance the glycan strands are made of N-acetylmuramic acid/MurNAc (MUB) and N-acetylglucosamine/GlcNAc (NAG) linked by beta-1,4 glycosidic bonds. Peptide stems, in this instance, are attach to MurNAc and consist of L-alanine, gamma D-glutamine/D-Gln (ZGL), meso-diaminopimelic acid/m-DAP (JGO), and D-alanine (DAP). | | Definition date: | 2024-10-16 | | Last modified: | 2024-10-16 |
|
 | | PRD_002546 | | Name: | NOSO-95179 antibiotic | | Formula: | C43 H79 N18 O11 | | Definition date: | 2024-10-09 | | Last modified: | 2024-10-09 |
|
 | | PRD_002540 | | Name: | evybactin | | Formula: | C64 H91 N21 O21 | | Definition date: | 2024-10-02 | | Last modified: | 2024-10-02 |
|
 | | PRD_002578 | | Name: | (2~{S},3~{R})-~{N}-[(5~{S},8~{S},10~{S})-5-methyl-10-oxidanyl-2,7-bis(oxidanylidene)-1,6-diazacyclododec-8-yl]-3-oxidanyl-2-(3-phenylpropanoylamino)butanamide | | Formula: | C24 H36 N4 O6 | | Definition date: | 2024-09-25 | | Last modified: | 2024-09-25 |
|
 | | PRD_002580 | | Name: | ~{N}-[(2~{S},3~{R})-1-[[(5~{S},8~{S},10~{S})-5-methyl-10-oxidanyl-2,7-bis(oxidanylidene)-1,6-diazacyclododec-8-yl]amino]-3-oxidanyl-1-oxidanylidene-butan-2-yl]-5-phenyl-pentanamide | | Formula: | C26 H40 N4 O6 | | Definition date: | 2024-09-25 | | Last modified: | 2024-09-25 |
|
 | | PRD_002234 | | Formula: | C57 H91 N12 O19 | | Definition date: | 2024-08-07 | | Last modified: | 2024-08-07 |
|
 | | PRD_000694 | | Name: | SYNTHETIC PEPTIDE PHQ-PRO-YCP | | Formula: | C19 H24 N2 O5 | | Definition date: | 2024-08-07 | | Last modified: | 2024-08-07 |
|
 | | PRD_000695 | | Name: | (2S)-1-[2-[(4-hydroxy-4-oxobutanoyl)amino]acetyl]pyrrolidine-2-carboxylic acid | | Formula: | C11 H16 N2 O6 | | Definition date: | 2024-08-07 | | Last modified: | 2024-08-07 |
|
 | | PRD_002539 | | Name: | [FIP-HRC]2-PEG11 | | Formula: | C28 H29 N3 O6 | | Definition date: | 2024-07-24 | | Last modified: | 2024-07-24 |
|
 | | PRD_002555 | | Name: | Paenilamicin B2 | | Formula: | C42 H86 N16 O13 | | Description: | Nonribosomally synthesized peptide-polyketide hybrid | | Definition date: | 2024-07-24 | | Last modified: | 2024-07-24 |
|
 | | PRD_002420 | | Name: | G2S2-oxazoline | | Formula: | C76 H124 N5 O56 | | Definition date: | 2024-07-03 | | Last modified: | 2024-07-03 |
|
 | | PRD_002423 | | Name: | Phytochelatin 2 | | Formula: | C18 H29 N5 O10 S2 | | Definition date: | 2024-06-19 | | Last modified: | 2024-06-19 |
|
 | | PRD_002429 | | Name: | cihanmycin G | | Formula: | C74 H87 N11 O22 | | Definition date: | 2024-06-19 | | Last modified: | 2024-06-19 |
|
 | | PRD_002337 | | Name: | INHIBITOR ARC-1411 | | Formula: | C61 H119 N34 O9 | | Definition date: | 2024-04-10 | | Last modified: | 2024-04-10 |
|
 | | PRD_002339 | | Name: | Inhibitor ARC-1415 | | Formula: | C55 H106 N30 O8 | | Definition date: | 2024-04-10 | | Last modified: | 2024-04-10 |
|
 | | PRD_002532 | | Name: | N-Methyl-D-Gln4,Lys10-teixobactin | | Formula: | C59 H100 N13 O15 | | Definition date: | 2024-03-06 | | Last modified: | 2024-03-06 |
|
 | | PRD_002557 | | Name: | Stapled peptide | | Formula: | C80 H104 N27 O17 | | Definition date: | 2024-03-06 | | Last modified: | 2024-03-06 |
|
